亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Outcomes Related to New Persistent Opioid Use after Surgery or Trauma

医学 类阿片 人口 急诊医学 内科学 环境卫生 受体
作者
Jiayi Gong,Peter Jones,Kebede Beyene,Chris Frampton,Amy Hai Yan Chan
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1097/sla.0000000000006509
摘要

Objectives: To evaluate the impact of persistent opioid use (POU) following surgery or trauma on health outcomes using linked data. Summary Background Data: Surgery and trauma can lead to POU, characterised by continuous opioid consumption following hospital discharge. Outside the US, there is a lack of population-based studies on POU outcomes in opioid-naïve patients following these events. Method: We included opioid-naïve patients who were dispensed opioids after being discharged following admission for surgery or trauma to any New Zealand (NZ) hospital from 2007-2019. Differences in outcomes between individuals with and without POU were assessed between 180-360 days after discharge. The primary outcome was all-cause mortality, the secondary outcomes were all-cause and opioid-related hospitalisation, and Days Alive and Out of Hospital (DAOH). Cox and quantile multivariable regression models were used to examine the association between POU and outcomes. Results: Overall, 298,928 surgical and 206,663 trauma patients were included in the final analyses, and 17,779 (5.9%) surgical and 17,867 (8.6%) trauma patients developed POU. POU was significantly associated with increased risk of all-cause mortality (surgical, aHR=6.59; 95% CI 5.82–7.46; trauma, aHR=2.77; 95% CI 2.47–3.11), all-cause hospitalisation (surgical, aHR=2.02; 95% CI 1.95–2.08; trauma, aHR=1.57; 95% CI 1.52–1.62), opioid-related hospitalisation (surgical, aHR=2.49; 95% CI 2.24–2.76; trauma, aHR=1.89; 95% CI 1.73–2.05) and reduced DAOH. Conclusions: Among opioid-naive patients who received opioids after surgery or trauma, POU was associated with worse outcomes, including increased mortality. Further investigation is warranted to understand the reasons for continued opioid use beyond 90 days and mechanisms associated with harm.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助糕点院士采纳,获得10
1秒前
酷波er应助微生采纳,获得10
1秒前
可耐的夜梅完成签到,获得积分10
1秒前
3秒前
3秒前
lily发布了新的文献求助10
7秒前
王钢门完成签到,获得积分10
8秒前
我的纸飞机完成签到,获得积分10
8秒前
9秒前
0000发布了新的文献求助10
9秒前
Mircale发布了新的文献求助10
10秒前
Macrophage完成签到,获得积分10
11秒前
12秒前
且歌且行完成签到,获得积分10
13秒前
王钢铁完成签到,获得积分10
14秒前
15秒前
18秒前
KamilahKupps发布了新的文献求助10
19秒前
手套完成签到,获得积分10
19秒前
22秒前
lindalin发布了新的文献求助10
22秒前
22秒前
行则将至发布了新的文献求助10
23秒前
田様应助且歌且行采纳,获得10
25秒前
77爱吃鱼完成签到,获得积分10
26秒前
EDTA完成签到,获得积分10
26秒前
e001应助Liuuuu采纳,获得10
27秒前
NightGlow发布了新的文献求助10
28秒前
29秒前
想不出来完成签到 ,获得积分10
31秒前
虞滢滢完成签到,获得积分20
32秒前
华仔应助eaglet120采纳,获得10
33秒前
34秒前
35秒前
反恐分子发布了新的文献求助10
35秒前
时尚以山完成签到 ,获得积分20
38秒前
虞滢滢发布了新的文献求助10
39秒前
粽子发布了新的文献求助10
39秒前
JamesPei应助fgmy采纳,获得30
43秒前
天天快乐应助xingxing采纳,获得25
44秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
Digital and Social Media Marketing 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5987845
求助须知:如何正确求助?哪些是违规求助? 7407926
关于积分的说明 16048331
捐赠科研通 5128422
什么是DOI,文献DOI怎么找? 2751733
邀请新用户注册赠送积分活动 1723027
关于科研通互助平台的介绍 1627028